PortfoliosLab logo

Aquestive Therapeutics, Inc. (AQST)

Equity · Currency in USD · Last updated Apr 1, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Aquestive Therapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $710 for a total return of roughly -92.90%. All prices are adjusted for splits and dividends.

AQST (Aquestive Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AQST

Aquestive Therapeutics, Inc.


Aquestive Therapeutics, Inc. had a return of 26.39% year-to-date (YTD) and -57.46% in the last 12 months. Over the past 10 years, Aquestive Therapeutics, Inc. had an annualized return of -43.18%, while the S&P 500 had an annualized return of 8.17%, indicating that Aquestive Therapeutics, Inc. did not perform as well as the benchmark.

1 month45.59%3.51%
6 months1.79%12.88%
1 year-57.46%-10.71%
5 years (annualized)-43.18%8.17%
10 years (annualized)-43.18%8.17%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aquestive Therapeutics, Inc. Sharpe ratio is -0.66. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

AQST (Aquestive Therapeutics, Inc.)
Benchmark (^GSPC)

Dividend History

Aquestive Therapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

AQST (Aquestive Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Aquestive Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aquestive Therapeutics, Inc. is 96.68%, recorded on Jul 1, 2022. The portfolio has not recovered from it yet.



To Bottom


To Recover



-96.68%Sep 10, 2018960Jul 1, 2022
-6.54%Jul 26, 20188Aug 6, 20185Aug 13, 201813
-6.17%Aug 15, 20189Aug 27, 20182Aug 29, 201811
-0.67%Sep 4, 20181Sep 4, 20182Sep 6, 20183

Volatility Chart

Current Aquestive Therapeutics, Inc. volatility is 80.16%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

AQST (Aquestive Therapeutics, Inc.)
Benchmark (^GSPC)